Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma

• Main Authors: Matthew D. Tucker (Author), Landon C. Brown (Author), Yu-Wei Chen (Author), Chester Kao (Author), Nathan Hirshman (Author), Emily N. Kinsey (Author), Kristin K. Ancell (Author), Kathryn E. Beckermann (Author), Nancy B. Davis (Author), Renee McAlister (Author), Kerry Schaffer (Author), Andrew J. Armstrong (Author), Michael R. Harrison (Author), Daniel J. George (Author), W. Kimryn Rathmell (Author), Brian I. Rini (Author), Tian Zhang (Author)
• Format: Book
• Published: BMC, 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background The identification of biomarkers to select patients with metastatic renal cell carcinoma (mRCC) most likely to respond to combination immunotherapy (IO) is needed. We sought to investigate an association of the baseline neutrophil-to-eosinophil ratio (NER) with outcomes to nivolu...